Edition:
United Kingdom

Dova Pharmaceuticals Inc (DOVA.OQ)

DOVA.OQ on NASDAQ Stock Exchange Global Market

16.55USD
12 Nov 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$16.55
Open
$17.05
Day's High
$17.20
Day's Low
$15.60
Volume
92,732
Avg. Vol
74,319
52-wk High
$35.52
52-wk Low
$15.60

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 2.93 -0.692
Jun '18 4.58 -0.697
Mar '18 0.00 -0.518
FY 2017 Dec '17 0.00 -0.362
Sep '17 0.00 -0.384
Jun '17 0.00 -0.224
Mar '17 0.00 -0.220
FY 2016 Dec '16 0.00 -0.163
Sep '16 0.00 -0.414
Jun '16 0.00 -0.419
Mar '16 0.00 -0.210
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 5 4.79 5.67 3.60 --
Quarter Ending Mar-19 2 9.22 10.44 8.00 --
Year Ending Dec-18 5 12.01 13.18 10.00 18.09
Year Ending Dec-19 5 63.03 79.43 41.00 163.47
Earnings (per share)
Quarter Ending Dec-18 5 -0.72 -0.66 -0.76 -0.17
Quarter Ending Mar-19 3 -0.62 -0.55 -0.66 0.88
Year Ending Dec-18 5 -2.69 -2.60 -2.79 -1.24
Year Ending Dec-19 5 -2.11 -1.04 -2.78 5.38
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 81.01 29.57
P/E High - Last 5 Yrs. -- 267.91 46.44
P/E Low - Last 5 Yrs. -- 85.11 24.51
Beta -- 0.74 0.88
Price to Sales (TTM) 63.40 232.78 15.43
Price to Book (MRQ) 5.06 16.33 4.06
Price to Tangible Book (MRQ) 5.06 20.88 13.80
Price to Cash Flow (TTM) -- 48.95 21.23
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.40 1.64
Dividend Yield - 5 Year Avg -- 0.22 1.45
Dividend 5 Year Growth Rate -- 3.72 -5.78
Payout Ratio(TTM) -- 7.81 41.88

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 148.87 7.10
Sales (TTM) vs TTM 1 Yr. Ago -- 63.88 5.63
Sales - 5 Yr. Growth Rate -- 22.16 7.39
EPS (MRQ) vs Qtr. 1 Yr. Ago -80.06 46.11 36.31
EPS (TTM) vs TTM 1 Yr. Ago -128.98 -- --
EPS - 5 Yr. Growth Rate -- 20.32 7.73
Capital Spending - 5 Yr. Growth Rate -- 34.35 8.00

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 7.40 3.36 2.55
Current Ratio (MRQ) 7.50 6.59 3.51
LT Debt to Equity (MRQ) 17.21 18.51 11.13
Total Debt to Equity (MRQ) 21.63 23.97 14.84
Interest Coverage (TTM) -28.28 -205.37 40.28

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 88.17 32.29 54.38
Gross Margin - 5 Yr. Avg. -- 47.38 52.96
EBITD Margin (TTM) -813.98 -- --
EBITD - 5 Yr. Avg -- -162.73 15.85
Operating Margin (TTM) -814.23 -1,819.18 -16.28
Operating Margin - 5 Yr. Avg. -- -175.96 11.08
Pre-Tax Margin (TTM) -828.58 -1,749.43 -14.67
Pre-Tax Margin - 5 Yr. Avg. -- -178.84 11.39
Net Profit Margin (TTM) -828.58 -1,744.55 -18.01
Net Profit Margin - 5 Yr. Avg. -- -178.80 7.65
Effective Tax Rate (TTM) -- 14.32 21.32
Effective Tax Rate - 5 Yr. Avg. -- 18.97 24.45

Efficiency

  Company industry sector
Revenue/Employee (TTM) 227,667 24,520,427 722,980,797
Net Income/Employee (TTM) -1,886,394 -3,918,019 83,628,555
Receivable Turnover (TTM) -- 8.33 5.19
Inventory Turnover (TTM) -- 2.80 4.12
Asset Turnover (TTM) 0.06 0.47 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -53.77 -0.91 10.15
Return on Assets - 5 Yr. Avg. -- 2.43 10.82
Return on Investment (TTM) -69.02 -0.53 12.77
Return on Investment - 5 Yr. Avg. -- 2.24 13.88
Return on Equity (TTM) -76.94 -3.22 14.47
Return on Equity - 5 Yr. Avg. -- -1.62 15.19
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -26.63 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Dova Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 46.14%
# of Holders: 101
Total Shares Held: 13,013,068
3 Mo. Net Change: -88,182
# New Positions: 6
# Closed Positions: 5
# Increased Positions: 29
# Reduced Positions: 14
# Net Buyers: 15
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.